About the Company
Becton, Dickinson and Company (BD; also Becton Dickinson or Becton) is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas. BD is ranked #211 in the 2024 Fortune 500 list based on its revenues for the fiscal year ending September 30, 2023.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
70093
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on BECTON DICKINSON & CO
Becton, Dickinson: Great Time To Buy This Dividend Aristocrat
Becton, Dickinson and Company, a leading medical technology firm, is focused on high-growth areas like biologics. Read what ...
Becton, Dickinson and Company Stock: Is Wall Street Bullish or Bearish?
With a market cap of $56.2 billion, Becton, Dickinson and Company (BDX) is a global medical technology leader that develops, ...
Surgical Equipment & Consumables - Diversified Stocks Q2 Results: Benchmarking BD (NYSE:BDX)
Let’s dig into the relative performance of BD (NYSE:BDX) and its peers as we unravel the now-completed Q2 surgical equipment ...
Becton Dickinson (BDX) Fell Due to Decline in Organic Revenue Growth
Kovitz Investment Group Partners, LLC, an investment management company, released its “Kovitz Core Equity Strategy” ...
Becton, Dickinson rises as strong Q3 results lead to guidance raise
Becton, Dickinson (BDX) stock gains as the company boosts fiscal 2025 earnings outlook after better than expected Q3 results.
Becton Dickinson shares surge as Q3 earnings beat drives guidance hike
Becton Dickinson shares surged over 8% in premarket trading on Thursday after the medical technology company reported ...
4 Overlooked Dividend Aristocrat Stocks with Up To 60%+ Growth Potential
Although it sounds like an oxymoron, high-growth prospect dividend aristocrat stocks exist, although their industries may ...
Becton Dickinson & Co. stock rises Monday, still underperforms market
The stock's rise snapped a five-day losing streak.
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors
Becton Dickinson & Co. closed 29.80% below its 52-week high of $251.99, which the company reached on February 3rd.
BD invests $35M to expand syringe plant in Nebraska
BD will invest $35M to expand its Nebraska syringe plant, adding 50 jobs and boosting U.S. supply of essential medical ...
Becton Dickinson joins peer in raising annual profit forecast after results beat
Becton Dickinson raised its forecast for annual profit on Thursday, after beating Wall Street estimates for third-quarter profit and sales on strong demand for its drug-delivery devices.
R.I. jury orders Becton Dickinson to pay $4.8 mln in hernia mesh trial
Becton, Dickinson and Co's C.R. Bard Inc subsidiary must pay $4.8 million in a lawsuit brought by a Hawaii man who said he suffered serious complications after being implanted with the company's ...
Similar Companies
Loading the latest forecasts...